Josh Brown on Pfizer (PFE): 'I Was Dead Wrong, There's No Turnaround'

Pfizer Inc (NYSE:PFE) is one of the Top 10 Stocks Wall Street is Buzzing About These Days.

Josh Brown, CEO of Ritholtz Wealth Management, explained in a recent program on CNBC why he’s bearish on Pfizer. Brown said he was “dead wrong” in hoping to see a turnaround at the pharma giant.

“Do you know how hard it is to find a stock as bad as Pfizer Inc (NYSE:PFE) like in the last couple of years? I managed the impossible. I haven’t really lost a lot of money here. I think my initial purchase was like 28. But it’s a loss nonetheless. But the way I think about these types of things, it’s a loss relative to the overall market having gone up so much, which makes it even worse. And I stuck to my guns on this for no reason. I’m not really a value investor. I just felt the stock was so hated and down so much that it was a relatively low-risk entry and at some point they’d find a way to turn it around. I was right about the low-risk entry part, but I was dead wrong. There is no turnaround. Maybe it’ll happen starting today now that I’m no longer in the stock.”

While we acknowledge the potential of PFE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.